Roche Unit Retains Trimmed Cancer Drug Patent At EPO
A Japanese Roche subsidiary can keep a snipped version of its European patent for a cancer drug after proving that its blueprint is detailed enough for a skilled person to carry...To view the full article, register now.
Already a subscriber? Click here to view full article